News & events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

ATS 2018, 18 – 23 May, San Diego, USA

21 May 2018

OncoArendi Therapeutics Gets Listed

18 December 2017

OncoArendi Therapeutics to Begin the Phase 1 Clinical Evaluation of its Novel Class of Medicines

9 October 2017

OncoArendi featured in Labiotech.eu

19 July 2017

OncoArendi Therapeutics announced today that it has filed a Clinical Trial Application (CTA)

7 July 2017

OncoArendi Therapeutics Announces Selection of Its Second Clinical Development Candidate: OATD-02 For the Treatment of Multiple Cancers

21 June 2017

Events & Presentations

ESMO – 8-12 September 2017 Madrid

1 September 2017

ERS – 9-13 September 2017 Milan

1 September 2017

BIO USA – San Diego 19-22 June 2017

1 June 2017

ATS – Washington 19-24 May 2017

1 May 2017